Recs

9

This Is the Next Big Opportunity With Drug Stocks

By Chris Hill | More Articles
November 30, 2011 | Comments (0)

The following video is part of our daily MarketFoolery podcast, in which host Chris Hill and analysts Alex Scherer and Jason Moser discuss business and investing news. In this segment, the guys discuss how big pharmaceutical companies are trying to overcome the rise of generic drugs, how intermediary players like CVS and Walgreen are benefiting, and which smaller pharmaceutical companies could be acquisition targets.

Merck is one of the companies highlighted in The Motley Fool's report on dividend stocks that are your best bet to beat inflation. It's called "13 High-Yielding Stocks to Buy Today," and you can get access to it right now at no cost. Simply click here -- it's free.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Chris Hill owns shares of Pfizer. The Motley Fool owns shares of National Oilwell Varco and Exelixis. Motley Fool newsletter services have recommended buying shares of Exelixis, Pfizer, and National Oilwell Varco. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1734148, ~/Articles/ArticleHandler.aspx, 5/26/2012 10:53:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
MRK $37.55 Down -0.05 -0.13%
Merck & Co., Inc. CAPS Rating: ****
NOV $68.10 Up +0.25 +0.37%
National Oilwell V… CAPS Rating: *****
EXEL $4.61 Up +0.03 +0.66%
Exelixis CAPS Rating: *****
CVS $44.98 Down -0.19 -0.42%
CVS Caremark Corp CAPS Rating: ****
ESRX $52.63 Up +0.96 +1.86%
Express Scripts, I… CAPS Rating: ****

Advertisement